Article
Moderna says FDA to review its flu vaccine after reversing course
Bearish
-55.0
−100 Bearish
0
+100 Bullish
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This